Try one of the below options to narrow down your search.
 |
Documents may be browsed by date, eg; Today, May, 2013.
Past years can be browsed too, eg; 2012, 2011, 2010, 2009 ...
Documents can be searched within a period by browsing to the date and then using the search form; or by direct links, eg; Media releases from 2013
Document tags (shown below the document date, eg; Schedule, SAForms, consultation ...) have highest priority when search results are ranked, followed by title, abstract and full text of document.
Parentheses and the keywords and, or and not have special meaning in search terms. And is implicit and can be omitted; or must be specified.
Remember to group or statements with parentheses if they are beside and statements.
Search examples
- consultation
- Search for consultations
- media and not antibiotics
- Search for media related documents that don't mention antibiotics.
- (media or consultation) and vaccines
- Search for media releases and consultation documents mentioning vaccinations.
Search term: archive
2009
PHARMAC documents that matched your search:
Notification of Silver sulphadiazine (Flamazine) funding
(1 page, 140 KB)
2009/12/15
15 December 2009 Silver sulphadiazine (Flamazine) funding approved PHARMAC is pleased to announce the approval of a supply agreement with Smith and Nephew Limited for silver sulphadiazine 1% cream (Flamazine). Smith and Nephew is discontinuing silver sulphadiazine 1% with 0.2%…
Notification for sole supply of somatropin
(3 pages, 175 KB)
2009/12/07
7 December 2009 Approval of sole supply arrangement for the biologic treatment, somatropin (growth hormone) PHARMAC is pleased to announce the approval of an agreement with Pfizer New Zealand Limited in relation to somatropin. This was the subject of a…
Notification of agreement with Novartis
(2 pages, 64 KB)
2009/12/04
4 December 2009 Proposal for cyclosporin, octreotide LAR and zoledronic acid approved PHARMAC is pleased to announce that the approval of an agreement with Novartis New Zealand Limited for the supply of Neoral (cyclosporin 25 mg, 50 mg and 100…
Notification of agreement with Pfizer
(3 pages, 42 KB)
2009/12/04
4 December 2009 Approval of agreement with Pfizer New Zealand Ltd for clindamycin (Dalacin C), sulphasalazine (Salazopyrin), cabergoline (Dostinex) and medroxyprogesterone (Provera and Depo-Provera) PHARMAC is pleased to announce the approval of an agreement with Pfizer New Zealand Limited for…
Notification of CSL proposal
(3 pages, 42 KB)
2009/12/04
4 December 2009 Solifenacin (Vesicare), mesalazine (Asamax) and hydrocortisone preparations funding approved PHARMAC is pleased to announce that the approval of a supply agreement with CSL Biotherapies for solifenacin (Vesicare), mesalazine (Asamax) and various hydrocortisone preparations. This was the subject…
Proposal to fund exemestane (Aromasin). Closed.
(2 pages, 141 KB)
2009/12/04
4 December 2009 Consultation on a proposal for the aromatase inhibitor exemestane (Aromasin) Summary of Proposal Following the announcement of PHARMAC’s decision to apply reference pricing to the subsidised aromatase inhibitors anastrozole and letrozole from 1 February 2010, PHARMAC is…
Release of the 2009/10 Invitation to Tender
(1 page, 137 KB)
2009/12/04
4 December 2009 Release of the 2009/10 Invitation to Tender PHARMAC wishes to advise that the PHARMAC Board has approved the 2009/10 Invitation to Tender, which has been distributed today via the electronic tender (eTender) system. A complete copy of…
Notification of Agreement with API Consumer Brands Ltd
(1 page, 35 KB)
2009/12/03
3 December 2009 Approval of agreement with API Consumer Brands Ltd for the listings of various pharmaceuticals on the Pharmaceutical Schedule PHARMAC is pleased to announce the approval of an agreement with API Consumer Brands for the supply of cholecalciferol…
Notification of Arrow-Topiramate and Arrow-Alprazolam decision
(2 pages, 40 KB)
2009/12/03
3 December 2009 Proposal for Arrow-Topiramate and Arrow-Alprazolam approved PHARMAC is pleased to announce the approval of an agreement with Arrow Pharmaceuticals (NZ) Limited to fund a new brand of topiramate tablets and reduce the price and subsidy for alprazolam.…
Notification of reference pricing subsidised aromatase inhibitors
(5 pages, 140 KB)
2009/12/03
2 December 2009 Approval of proposal relating to reference pricing subsidised aromatase inhibitors PHARMAC is pleased to announce the approval of a proposal to reference price subsidised aromatase inhibitors; specifically, anastrozole and letrozole. This decision will result in savings to…
